Taiko Pharmaceutical Co.,Ltd. (4574.T)
JPY 273.0
(-0.73%)
JPY 273.0
(-0.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 704 Million JPY | 168.82% |
| 2021 | -1.02 Billion JPY | 78.91% |
| 2020 | -4.84 Billion JPY | 50.65% |
| 2019 | -9.82 Billion JPY | -37.08% |
| 2018 | -7.16 Billion JPY | -9.99% |
| 2017 | -6.51 Billion JPY | 3.71% |
| 2016 | -6.76 Billion JPY | -129.1% |
| 2015 | -2.95 Billion JPY | 25.36% |
| 2014 | -3.95 Billion JPY | 53.44% |
| 2013 | -8.5 Billion JPY | -65.25% |
| 2012 | -5.14 Billion JPY | -11.32% |
| 2011 | -4.62 Billion JPY | -11.88% |
| 2010 | -4.13 Billion JPY | 18.37% |
| 2009 | -5.06 Billion JPY | -53.51% |
| 2008 | -3.29 Billion JPY | -15.56% |
| 2007 | -2.85 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -1.61 Billion JPY | -616.99% |
| 2023 Q1 | 312 Million JPY | -55.68% |
| 2023 Q3 | -1.79 Billion JPY | -11.41% |
| 2022 Q1 | -1.9 Billion JPY | -85.83% |
| 2022 FY | 704 Million JPY | 168.82% |
| 2022 Q4 | 704 Million JPY | 28.94% |
| 2022 Q3 | 546 Million JPY | 210.08% |
| 2022 Q2 | -496 Million JPY | 73.91% |
| 2021 Q2 | -1.91 Billion JPY | 48.3% |
| 2021 Q4 | -1.02 Billion JPY | 8.74% |
| 2021 Q3 | -1.12 Billion JPY | 41.49% |
| 2021 FY | -1.02 Billion JPY | 78.91% |
| 2021 Q1 | -3.7 Billion JPY | 0.0% |
| 2020 Q2 | -8.98 Billion JPY | 8.62% |
| 2020 FY | -4.84 Billion JPY | 50.65% |
| 2020 Q1 | -9.82 Billion JPY | -68.35% |
| 2020 Q3 | -8.47 Billion JPY | 5.6% |
| 2019 FY | -9.82 Billion JPY | -37.08% |
| 2019 Q1 | -7.16 Billion JPY | -31.72% |
| 2019 Q2 | -6.9 Billion JPY | 3.75% |
| 2019 Q4 | -5.83 Billion JPY | 2.34% |
| 2019 Q3 | -5.97 Billion JPY | 13.38% |
| 2018 FY | -7.16 Billion JPY | -9.99% |
| 2018 Q2 | -6.47 Billion JPY | 0.61% |
| 2018 Q1 | -6.51 Billion JPY | -27.43% |
| 2018 Q3 | -5.49 Billion JPY | 15.25% |
| 2018 Q4 | -5.44 Billion JPY | 0.87% |
| 2017 Q3 | -5.21 Billion JPY | 16.52% |
| 2017 FY | -6.51 Billion JPY | 3.71% |
| 2017 Q4 | -5.11 Billion JPY | 1.89% |
| 2017 Q2 | -6.24 Billion JPY | 7.74% |
| 2017 Q1 | -6.76 Billion JPY | -77.96% |
| 2016 Q4 | -3.8 Billion JPY | 2.28% |
| 2016 Q2 | -2.94 Billion JPY | 0.38% |
| 2016 Q3 | -3.89 Billion JPY | -32.24% |
| 2016 FY | -6.76 Billion JPY | -129.1% |
| 2016 Q1 | -2.95 Billion JPY | -301.97% |
| 2015 Q1 | -3.95 Billion JPY | 2.0% |
| 2015 Q4 | -735.08 Million JPY | 30.73% |
| 2015 FY | -2.95 Billion JPY | 25.36% |
| 2015 Q2 | -2.62 Billion JPY | 33.65% |
| 2015 Q3 | -1.06 Billion JPY | 59.6% |
| 2014 Q2 | -6.6 Billion JPY | 22.34% |
| 2014 FY | -3.95 Billion JPY | 53.44% |
| 2014 Q3 | -4.76 Billion JPY | 27.89% |
| 2014 Q1 | -8.5 Billion JPY | -46.53% |
| 2014 Q4 | -4.03 Billion JPY | 15.15% |
| 2013 Q4 | -5.8 Billion JPY | 1.1% |
| 2013 Q1 | -5.14 Billion JPY | -22.0% |
| 2013 Q2 | -5.47 Billion JPY | -6.33% |
| 2013 FY | -8.5 Billion JPY | -65.25% |
| 2013 Q3 | -5.86 Billion JPY | -7.25% |
| 2012 FY | -5.14 Billion JPY | -11.32% |
| 2012 Q4 | -4.21 Billion JPY | -3.33% |
| 2012 Q3 | -4.08 Billion JPY | 10.46% |
| 2012 Q2 | -4.55 Billion JPY | 1.38% |
| 2012 Q1 | -4.62 Billion JPY | -20.66% |
| 2011 Q3 | -3.67 Billion JPY | 7.0% |
| 2011 Q4 | -3.83 Billion JPY | -4.36% |
| 2011 FY | -4.62 Billion JPY | -11.88% |
| 2011 Q2 | -3.94 Billion JPY | 4.46% |
| 2011 Q1 | -4.13 Billion JPY | -44.8% |
| 2010 FY | -4.13 Billion JPY | 18.37% |
| 2010 Q1 | -5.06 Billion JPY | -24.09% |
| 2010 Q2 | -3.61 Billion JPY | 28.56% |
| 2010 Q4 | -2.85 Billion JPY | 5.96% |
| 2010 Q3 | -3.03 Billion JPY | 16.08% |
| 2009 Q2 | -2.74 Billion JPY | 16.69% |
| 2009 Q3 | -2.94 Billion JPY | -7.07% |
| 2009 Q4 | -4.07 Billion JPY | -38.7% |
| 2009 Q1 | -3.29 Billion JPY | 0.0% |
| 2009 FY | -5.06 Billion JPY | -53.51% |
| 2008 FY | -3.29 Billion JPY | -15.56% |
| 2007 FY | -2.85 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 42.531% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.984% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 99.819% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 100.203% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 119.752% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 101.67% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 101.145% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 100.719% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 205.547% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 101.359% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 102.138% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 90.739% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 90.952% |
| Tsumura & Co. | 1.61 Billion JPY | 56.409% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 101.594% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 102.044% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 99.592% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 97.356% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 97.571% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 90.028% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 88.251% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 110.803% |
| MedRx Co., Ltd | -1.72 Billion JPY | 140.93% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 108.077% |
| Solasia Pharma K.K. | -668 Million JPY | 205.389% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 147.861% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 109.706% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 98.754% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 123.778% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 100.715% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 106.325% |